Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target.
about
The combination of an HDAC6 inhibitor and a somatostatin receptor agonist synergistically reduces hepato-renal cystogenesis in an animal model of polycystic liver disease.Dorsal Root Ganglion Maintains Stemness of Bone Marrow Mesenchymal Stem Cells by Enhancing Autophagy through the AMPK/mTOR Pathway in a Coculture System
P2860
Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Cholangiocyte autophagy contri ...... potential therapeutic target.
@en
Cholangiocyte autophagy contri ...... potential therapeutic target.
@nl
type
label
Cholangiocyte autophagy contri ...... potential therapeutic target.
@en
Cholangiocyte autophagy contri ...... potential therapeutic target.
@nl
prefLabel
Cholangiocyte autophagy contri ...... potential therapeutic target.
@en
Cholangiocyte autophagy contri ...... potential therapeutic target.
@nl
P2093
P2860
P356
P1433
P1476
Cholangiocyte autophagy contri ...... potential therapeutic target.
@en
P2093
Anatoliy I Masyuk
Bing Q Huang
Jingyi Francess Ding
Lorena Loarca
Maria J Lorenzo Pisarello
Nicholas F LaRusso
Tatyana V Masyuk
P2860
P356
10.1002/HEP.29577
P407
P577
2017-10-10T00:00:00Z